These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29604332)

  • 1. Effects of hydrochlorothiazide and amlodipine on single oral dose pharmacokinetics of valsartan in healthy Korean subjects: Population model-based approach.
    Ngo L; Cho HY; Lee YB
    Eur J Pharm Sci; 2018 Jun; 118():154-164. PubMed ID: 29604332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
    Assaad-Khalil SH; Najem R; Sison J; Kitchlew AR; Cho B; Ueng KC; DiTommaso S; Shete A
    Vasc Health Risk Manag; 2015; 11():71-8. PubMed ID: 25653536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic interactions of valsartan and hydrochlorothiazide: an open-label, randomized, 4-period crossover study in healthy Egyptian male volunteers.
    Hedaya MA; Helmy SA
    Clin Ther; 2013 Jun; 35(6):846-61. PubMed ID: 23795576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world clinical experience of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in hypertension: the EXCITE study.
    Sison J; Assaad-Khalil SH; Najem R; Kitchlew AR; Cho B; Ueng KC; Shete A; Knap D
    Curr Med Res Opin; 2014 Oct; 30(10):1937-45. PubMed ID: 25007309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of food on the oral bioavailability of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide fixed dose combination tablets in healthy subjects.
    Sunkara G; Jiang X; Reynolds C; Serra D; Zhang Y; Ligueros-Saylan M; Ayalasomayajula S; Winter S; Jarugula V
    Clin Pharmacol Drug Dev; 2014 Nov; 3(6):487-92. PubMed ID: 27129123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized, and double-blind phase IV clinical trial to compare the efficacy and safety of fixed-dose combinations of amlodipine orotate/valsartan 5/160 mg versus valsartan/hydrochlorothiazide 160/12.5 mg in patients with essential hypertension uncontrolled by valsartan 160 mg monotherapy.
    Ahn Y; Kim Y; Chang K; Kim W; Rhee MY; Cha KS; Hyon MS; Shim CY; Lee SY; Kim DI; Kim SW; Lim SW; Han KR; Jo SH; Lee NH; Kwan J; Ahn T
    Medicine (Baltimore); 2018 Sep; 97(37):e12329. PubMed ID: 30212981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and effectiveness of valsartan/amlodipine and valsartan/amlodipine/hydrochlorothiazide in hypertension: randomized controlled versus observational studies.
    Sison J; Vega RMR; Dayi H; Bader G; Brunel P
    Curr Med Res Opin; 2018 Mar; 34(3):501-515. PubMed ID: 29210288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-life effectiveness, safety, and tolerability of amlodipine/valsartan or amlodipine/valsartan/hydrochlorothiazide single-pill combination in patients with hypertension from Pakistan.
    Khan W; Moin N; Iktidar S; Sakrani J; Abid R; Afzal J; Maheshwary N; Kumar K; Siddiqi A; Qadir M
    Ther Adv Cardiovasc Dis; 2014 Apr; 8(2):45-55. PubMed ID: 24562476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative model for the blood pressure-lowering interaction of valsartan and amlodipine.
    Heo YA; Holford N; Kim Y; Son M; Park K
    Br J Clin Pharmacol; 2016 Dec; 82(6):1557-1567. PubMed ID: 27504853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients.
    Destro M; Crikelair N; Yen J; Glazer R
    Vasc Health Risk Manag; 2010 Sep; 6():821-7. PubMed ID: 20859551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic comparison of amlodipine adipate/valsartan fixed-dose combination with amlodipine besylate/valsartan fixed-dose combination in healthy volunteers.
    Nam JH; Oh M; Kim HJ; Han SK; Kim EJ; Song GS; Kim EY; Shin JG; Ghim JL; Kim HS
    Int J Clin Pharmacol Ther; 2015 Jan; 53(1):66-74. PubMed ID: 25034618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new strategy for taste masking on bitter drug by other combined drug in fixed-dose combination: bitterness of Amlodipine besylate could be masked efficiently by Valsartan.
    Kojima H; Nakamura S; Haraguchi T; Yoshida M; Habara M; Ikezaki H; Uchida T
    J Pharm Pharmacol; 2019 Sep; 71(9):1384-1392. PubMed ID: 31273801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic Interaction Among Telmisartan, Amlodipine, and Hydrochlorothiazide After a Single Oral Administration in Healthy Male Subjects.
    Moon SJ; Jeon JY; Yu KS; Kim MG
    Clin Ther; 2019 Nov; 41(11):2273-2282. PubMed ID: 31564513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medication of the month. Exforge HCT: combination of amlodipine besylate, valsartan and hydrochlorothiazide in a single tablet].
    Lancellotti P
    Rev Med Liege; 2010; 65(7-8):471-5. PubMed ID: 20857707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of single and multiple oral doses of valsartan/amlodipine (80/5 mg) in healthy Chinese subjects.
    Duan J; Chen J; Yin Q; Karan R; Meiser K; Smith HT; Sunkara G
    Int J Clin Pharmacol Ther; 2012 Jan; 50(1):33-43. PubMed ID: 22192643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic comparison of 2 fixed-dose combination tablets of amlodipine and valsartan in healthy male Korean volunteers: a randomized, open-label, 2-period, single-dose, crossover study.
    Kim Y; Son M; Lee D; Roh H; Son H; Chae D; Bahng MY; Park K
    Clin Ther; 2013 Jul; 35(7):934-40. PubMed ID: 23870605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers.
    Vaidyanathan S; Valencia J; Kemp C; Zhao C; Yeh CM; Bizot MN; Denouel J; Dieterich HA; Dole WP
    Int J Clin Pract; 2006 Nov; 60(11):1343-56. PubMed ID: 17073832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologically Based Pharmacokinetic Modeling of Fimasartan, Amlodipine, and Hydrochlorothiazide for the Investigation of Drug-Drug Interaction Potentials.
    Rhee SJ; Lee HA; Lee S; Kim E; Jeon I; Song IS; Yu KS
    Pharm Res; 2018 Oct; 35(12):236. PubMed ID: 30324316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial.
    Calhoun DA; Lacourcière Y; Chiang YT; Glazer RD
    Hypertension; 2009 Jul; 54(1):32-9. PubMed ID: 19470877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertension.
    Calhoun DA; Lacourcière Y; Crikelair N; Jia Y; Glazer RD
    Curr Med Res Opin; 2013 Aug; 29(8):901-10. PubMed ID: 23721363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.